Coulter Investment Forum

Coulter Investment Forum

Each year, the Coulter Investment Forum showcases between 25 and 30 start-up companies with life science innovations de-risked using the Coulter Commercialization Process.
Coulter Commercialization Process
The Coulter Commercialization Process is a documented 27 step process utilizing industry best practices.  Its goal is to accelerate academic innovations to the market to improve patient care by reducing risk and attracting follow-on-funding. To be considered for participation, each company must have a CEO, a solution to a large unmet clinical need that is capable of changing medical practice, and an addressable market large enough to attract an industry partner, venture capital, and/or angel investment.   The presenting companies are submitted by the 16 Coulter Translational Partner Universities. Learn more about the  Coulter Investment Forum  and view the company presentations.